✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous
Market Cap
₹16 Cr.
P/E
158.56
  • Natural Biocon (I)
  • Quasar India
  • Golden Bull Research

FAQs on Natural Biocon (India) Ltd. Shareprice

Natural Biocon (I) has given lower returns compared to its competitors.
Natural Biocon (I) has grown at ~-16.27% over the last 5yrs while peers have grown at a median rate of 0.0%

Natural Biocon (I) is not expensive.
Latest PE of Natural Biocon (I) is 157, while 3 year average PE is 174.
Also latest EV/EBITDA of Natural Biocon (I) is 159 while 3yr average is 252.

Growth Table

  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Balance Sheet

  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Cash Flow

  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Quarterly Results

  • Natural Biocon (India) Ltd.
  • Quasar India
  • Golden Bull Research

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Natural Biocon (India) Ltd. Financials

Natural Biocon (I) balance sheet is weak and might have solvency issues

Yes, The net debt of Natural Biocon (I) is increasing.
Latest net debt of Natural Biocon (I) is ₹0.24 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹0.12 Crs.

The profit is oscillating.
The profit of Natural Biocon (I) is ₹0.15 Crs for Mar 2024, ₹0.18 Crs for Mar 2023 and ₹0.07 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Natural Biocon (I) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech